Inhibition of mutagenic PhIP formation by epigallocatechin gallate via scavenging of phenylacetaldehyde.
Chemical model investigation showed that both epigallocatechin gallate (EGCG) and its peracetate, which has all the hydroxyl groups acetylated, effectively reduced the formation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), the most abundant mutagenic heterocyclic amine found in foods. Mechanistic study was subsequently carried out to characterize the probable inhibitory mechanism involved. GC-MS analysis showed that EGCG in only one-fourth molar quantity of phenylalanine reduced formation of phenylacetaldehyde, a key PhIP intermediate by nearly 90%. Its peracetate also showed similar inhibitory activity. This further supported the existence of an antioxidant-independent mechanism contributing to the inhibition of PhIP formation by EGCG. Subsequent LC-MS analyses of samples from a wide range of model systems consisting of PhIP precursors showed the generation of characteristic analytes with molecular weight corresponding to the sum of EGCG and phenylalanine fragment(s) only in models where phenylalanine and EGCG were simultaneously present. An isotope-labeling study revealed that these analytes all contained fragment(s) of phenylalanine origin. Direct reaction employing phenylacetaldehyde and EGCG further confirmed the capability of EGCG to form adducts with phenylacetaldehyde, thus reducing its availability for PhIP formation. Finally, an investigation of the time course of the generation of postulated adduction products supported EGCG as an effective inhibitor of PhIP formation in prolonged heating processes.
Cheng
Ka-Wing
KW
School of Biological Sciences, The University of Hong Kong, Hong Kong, P. R. China.
Wong
Chi Chun
CC
Chao
Jianfei
J
Lo
Clive
C
Chen
Feng
F
Chu
Ivan K
IK
Che
Chi-Ming
CM
Ho
Chi-Tang
CT
Wang
Mingfu
M
D000079:Acetaldehyde / Q000031:analogs & derivatives* / Q000378:metabolism; D016587:Antimutagenic Agents / Q000494:pharmacology*; D002392:Catechin / Q000031:analogs & derivatives* / Q000494:pharmacology; D007093:Imidazoles / Q000378:metabolism*; D009153:Mutagens / Q000378:metabolism*
D016587:Antimutagenic Agents; D007093:Imidazoles; D009153:Mutagens; D002392:Catechin; C049584:2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine; C045651:epigallocatechin gallate; D000079:Acetaldehyde; C013192:phenylacetaldehyde